Clinical Trial Update: Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating liposomal amphotericin B for cancer patients with granulocytopenia and persistent unexplained fever has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Liposomal Amphotericin B (AmBisome) (liposomal amphotericin B)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Cancer | Phase 3 | Status: COMPLETED